Companion Animal Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00004558
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 241
Buy Now

Companion Animal Diagnostics Market Scope and Analysis Report by 2030

Buy Now

Companion Animal Diagnostics Market Report Companion Animal Diagnostics Market Size and Share Companion Animal Diagnostics Market Scope and Analysis

Companion Animal Diagnostics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 3.14 Billion
Market Size by 2030 US$ 6.3 Billion
Global CAGR (2022 - 2030) 9.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Technique
  • Immunodiagnostics
  • Clinical Biochemistry
  • Molecular Diagnostics
  • Urinalysis
  • Hematology
By Product
  • Instruments and Consumables
By Application
  • Bacteriology
  • Clinical Pathology
  • Virology
  • Parasitology
By Companion Animal Type
  • Dogs
  • Cats
  • Horses
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Demeditec Diagnostics GmbH
  • ARI Medical Technology Co Ltd
  • Tianjin LOCMEDT Technologies Co Ltd
  • Heska Corp
  • Innovative Diagnostics SAS
  • i SENS Inc
  • Universal Biosensors Inc
  • Immunology Consultants Laboratory Inc
  • Zoetis Inc

    • Industry Developments and Future Opportunities: 

    Various initiatives by key players operating in theCompanion Animal Diagnostics Market are listed below:

    1. In October 2023, Basepaws launched the most extensive DNA test for dogs, focused on health and early detection of disease risk. Basepaws Breed + Health Dog DNA Test assists pet owners in shifting from reactive to proactive care by providing simple swabbing and mobile-friendly results for a more convenient experience.
    2. In September 2023, Zoetis Inc completed the acquisition of Jurox, a privately held animal health firm that develops, manufactures, and markets a diverse range of veterinary pharmaceuticals for the treatment of livestock and companion animals. With the purchase of Jurox, Zoetis gains a number of critical medicines poised for global expansion; a valuable animal health portfolio, including Alfaxan, a leading anesthetic product for companion animals; and high-quality local R&D and manufacturing capabilities in Australia.  

    Competitive Landscape and Key Companies:

    A few prominent players operating in the companion animal diagnostics market are Demeditec Diagnostics GmbH, ARI Medical Technology Co Ltd, Tianjin LOCMEDT Technologies Co Ltd, Heska Corp, Innovative Diagnostics SAS, i-SENS Inc, Universal Biosensors Inc, Immunology Consultants Laboratory Inc, Zoetis Inc, and Elabscience Biotechnology Inc. These companies focus on new product launches and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.